» Download Public Reports
90 reports
- Company report
- April 2013
- 3 pages
- by Governmental Agency
January 2013
... As a byproduct of liposuction. The use of adult stem cells side-steps potential ethical issues surrounding the therapeutic use of embryonic stem cells. Eascs also possess advantages over other types of stem ...
November 2012
... Celect at its european manufacturing plant in sittard-geleen in the netherlands. The state- of-the-art manufacturing site is unique in europe as it is 100% geared towards the production of innovative cell ...
November 2012
... For the discovery that mature cells can be reprogrammed to become pluripotent Fda gave the green light for duke university to use stem cells found in umbilical cord blood to treat cancer, blood disorders ...
November 2012
... Ro; at, lt, mt, pl, sk). Source ege opinion 22 stem cell therapy as commodities - Eu law The politics of biotechnology at the eu was subordinated To that of the member states. Basic questions ...
November 2012
... Celect at its european manufacturing plant in sittard-geleen in the netherlands. The state- of-the-art manufacturing site is unique in europe as it is 100% geared towards the production of innovative cell ...
October 2012
... At osiris as we move rapidly into the commercialization of stem cell medicine," said c. Randal mills, ph.D., President and chief executive officer of osiris. "Over the past six years, lode has proven ...
October 2012
... At osiris as we move rapidly into the commercialization of stem cell medicine," said c. Randal mills, ph.D., President and chief executive officer of osiris. "Over the past six years, lode has proven ...
» Purchase Premium Reports
(From $ 250 - $ 1 500)
About 100 reports
- $ 1 500
- Company report
- May 2013
- by Global Markets Direct
Cytokine PharmaSciences, Inc. - Product Pipeline Review - 2013 Summary Global Market Direct's pharmaceuticals report, ?Cytokine PharmaSciences, Inc. - Product Pipeline Review - 2013? provides data on ...
June 2013
$ 1 200
Gene therapy is the treatment of a disease by replacing, altering, or supplementing a gene that is absent or abnormal and whose absence or abnormality is causing the disease. It has evolved as one of the ...
May 2013
$ 250
Summary Cryo-Cell International, Inc. (Cryo-Cell) is a biotechnology company, based in the US. The company's activities include cellular processing and cryogenic cellular storage, with a focus on the collection ...